Resultados de la búsqueda 801-810 of 17654 for dietary modifications

1. Salud de los consumidores Multimedia - Mayo Clinic

   U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/mixing-medications-and-dietary-supplements-can-endanger-your-health.

2. Pérdida de peso Fitness basics - Mayo Clinic

   The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Interested in losing weight? Nutrition.gov. https://www.nutrition.gov/topics/healthy-living-and-weight/ ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...

7. Pérdida de peso - Mayo Clinic

   The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Interested in losing weight? Nutrition.gov. https://www.nutrition.gov/topics/healthy-living-and-weight/ ...

8. Oncología (médica) - Ensayos clínicos

   Diet may affect cytokine levels and inflammation (8). Diet rich in trans-fat and sugar has been shown to increase pro-inflammatory cytokines IL-6 and TNFα (9, ...

9. Pérdida de peso Weight-loss basics - Mayo Clinic

   The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Interested in losing weight? Nutrition.gov. https://www.nutrition.gov/topics/healthy-living-and-weight/ ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...